Favorite Annette F 4

4 · WEST PHARMACEUTICAL SERVICES INC · Filed Sep 1, 2023

Form 4

Period: 2023-08-30

Sr. VP & Chief HR Officer

Transactions

Exercise/Conversion
Common Stock
2023-08-30$83.47/sh+2,000$166,940→ 16,876.962 total
Sale
Common Stock
[F1]
2023-08-30$414.19/sh−760$314,788→ 16,116.962 total
Sale
Common Stock
[F2]
2023-08-30$414.91/sh−1,240$514,489→ 14,876.962 total
Exercise/Conversion
Stock Options (Right to buy)
[F3]
2023-08-30−2,000→ 8,452 total
Exercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (2,000 underlying)

Footnotes (3)

[F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $413.58 to $414.57, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
[F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $414.58 to $415.08, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
[F3]This option is fully vested.

Signature

Ryan Metz as Agent for Annette F. Favorite|2023-09-01

Documents

1 file